|
At DM, we are dedicated in assisting pharmaceutical development by providing exemplary focus
on four key areas:
Site Recruitment
Patient Enrollment
Data Collection
Compliance DM is committed to ensuring high quality throughout the screening and enrollment process.
We have aligned ourselves with several qualified Board Certified Private Investigators with a diverse range of specialties to meet the challenges of drug development. This alliance gives us access to a database in excess of 125,000 potential study subjects for recruitment in Phase II through IV clinical trials. Furthermore, our highly educated staff is trained to thoroughly screen and obtain consent of all patients to ensure ideal subjects for each trial.
DM understands that quality in data collection and compliance is just as important as executing functions in a timely fashion.
We specialize in fast turnaround time and execution in the following areas:
Contracts and budget approval and finalization Regulatory documentation, including use of central IRB and preparation of 1572 and other regulatory documentation Recruitment of sites and appropriate private medical practices for study-specific therapeutic areas Scheduling of pre-site visits and facilitating with the CRO and/or sponsor for rapid study start-up and site initiation We hold our staff members to the highest standards to ensure that you receive the highest quality in data collection.
Our main objective at DM is to provide quality to our clients. We have the unique position of catering to two different groups of clients: 1. PIs and patients and 2. Sponsors/CROs. How do we manage to accommodate two different clients? Our staff consists of medically experienced individuals with a passion for clinical research. Many of our coordinators and managers are medical graduates and all team members have experience and training in the medical field. This allows us to develop and maintain long-lasting relationships with physicians who are able to communicate with our staff on a higher level. It also allows our coordinators to thoroughly inform patients on the study protocol.
Our medically experienced management staff oversees all aspects of the clinical trial, including study budgets, contracts, IRB submissions, and regulatory paperwork, which in turn enables us to provide exemplary quality in compliance. Internal quality assurance controls ensures accurate and timely data collection. We have mastered the art of linking the patient to the pharmaceutical company by providing a single contact point for access to multiple sites and therapeutic areas.
|